Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

Jeffrey L. Wolf, David Siegel, Hartmut Goldschmidt, Katharine Hazell, Priscille M. Bourquelot, Bourras R. Bengoudifa, Jeffrey Matous, Ravi Vij, Margarida De Magalhaes-Silverman, Rafat Abonour, Kenneth C. Anderson, Sagar Lonial

Research output: Contribution to journalLetterpeer-review

112 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.